Maryland State Retirement & Pension System’s Tvardi Therapeutics TVRD Stock Holding History

Maryland State Retirement & Pension System’s Portfolio TVRD Stock Details TVRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-513	Closed	-$198K	–	1549
2022 Q4	$198K	Hold	513	–	–	0.01%	1454
2022 Q3	$173K	Buy	513 +38	+8%	+$13.8K	0.01%	504
2022 Q2	$156K	Hold	475	–	–	0.01%	1463
2022 Q1	$208K	Buy	475 +15	+3%	+$6.16K	0.01%	1452
2021 Q4	$202K	Sell	460 -9	-2%	-$4.52K	0.01%	1483
2021 Q3	$261K	Buy	+469	New	+$235K	0.01%	1427

Other funds holding TVRD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Maryland State Retirement & Pension System's TVRD Position: Q1 2023 in Review

Maryland State Retirement & Pension System sold out of Tvardi Therapeutics (TVRD) in Q1 2023, closing a stake of 513 shares — an estimated $198K sold.

Maryland State Retirement & Pension System first reported a position in TVRD in Q3 2021 and held it in 6 quarters. The position peaked at $261K in Q3 2021. 163 funds tracked by Wall St. Rank hold TVRD as of Q1 2023.

Maryland State Retirement & Pension System reported no remaining Tvardi Therapeutics position as of Q1 2023 after selling out during the quarter.
Maryland State Retirement & Pension System sold 513 Tvardi Therapeutics shares in Q1 2023, an estimated $198K.
Maryland State Retirement & Pension System first reported a position in Tvardi Therapeutics in Q3 2021 and held it in 6 quarters.
Maryland State Retirement & Pension System's Tvardi Therapeutics position peaked at $261K in Q3 2021.
163 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q1 2023.

Based on Maryland State Retirement & Pension System's 13F filing for Q1 2023, filed 20 Apr 2023.